Established in 1973, Johnson & Johnson Development Corporation (JJDC) serves as the strategic venture capital arm of Johnson & Johnson, focusing on investments in pharmaceuticals, medical devices, and consumer health sectors. JJDC invests across all stages, from early-stage seed and Series A rounds through later-stage Series B and C financing, aiming to identify and accelerate transformative ideas that align with Johnson & Johnson's core strategic areas.
Is Johnson & Johnson Development Corporation the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Johnson & Johnson Development Corporation, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
US$1,000,000 - US$20,000,000
When engaging JJDC, founders should highlight how their innovation can integrate with or enhance existing healthcare ecosystems, particularly those with clear pathways to clinical validation and regulatory approval. Demonstrating a strong understanding of market access, scalability, and the potential for strategic partnership or acquisition will resonate, as JJDC values ventures that can leverage Johnson & Johnson’s global reach. Emphasize robust scientific data, differentiated technology, and a clear vision for patient impact to stand out in their rigorous evaluation process.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.